R. Sood, Y. Kamikubo, and P. Liu, Role of RUNX1 in hematological malignancies, Blood, vol.129, pp.2070-2082, 2017.

A. D. Yzaguirre, M. F. De-bruijn, and N. A. Speck, The role of Runx1 in embryonic blood cell formation, Adv. Exp. Med. Biol, vol.962, pp.47-64, 2017.

G. Brady, C. Elgueta-karstegl, and P. J. Farrell, Novel function of the unique N-terminal region of RUNX1c in B cell growth regulation, Nucleic Acids Res, vol.41, pp.1555-1568, 2013.

K. Hayashi, W. Natsume, T. Watanabe, N. Abe, N. Iwai et al., Diminution of the AML1 transcription factor function causes differential effects on the fates of CD4 and CD8 single-positive T cells, J. Immunol, vol.165, pp.6816-6824, 2000.

G. Huang, P. Zhang, H. Hirai, S. Elf, X. Yan et al., PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis, Nat. Genet, vol.40, pp.51-60, 2008.

M. Ichikawa, T. Asai, S. Chiba, M. Kurokawa, and S. Ogawa, Runx1/AML-1 ranks as a master regulator of adult hematopoiesis, Cell Cycle, vol.3, pp.722-724, 2004.

M. Ichikawa, A. Yoshimi, M. Nakagawa, N. Nishimoto, N. Watanabe-okochi et al., A role for RUNX1 in hematopoiesis and myeloid leukemia, Int. J. Hematol, vol.97, pp.726-734, 2013.

R. B. Lorsbach, J. Moore, S. O. Ang, W. Sun, N. Lenny et al., Role of RUNX1 in adult hematopoiesis: analysis of RUNX1-IRES-GFP knock-in mice reveals differential lineage expression, Blood, vol.103, pp.2522-2529, 2004.

T. Okuda, J. Van-deursen, S. W. Hiebert, G. Grosveld, and J. R. Downing, AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis, Cell, vol.84, pp.321-330, 1996.

Q. Wang, T. Stacy, M. Binder, M. Marin-padilla, A. H. Sharpe et al., Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis, Proc. Natl. Acad. Sci. U.S.A, vol.93, pp.3444-3449, 1996.

C. Bonifer, E. Levantini, V. Kouskoff, and G. Lacaud, Runx1 structure and function in blood cell development, Adv. Exp. Med. Biol, vol.962, pp.65-81, 2017.

Y. Ito, S. Bae, and L. S. Chuang, The RUNX family: developmental regulators in cancer, Nat. Rev. Cancer, vol.15, pp.81-95, 2015.

G. Huang, K. Shigesada, K. Ito, H. Wee, T. Yokomizo et al., Dimerization with PEBP2 protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation, EMBO J, vol.20, pp.723-733, 2001.

Q. Wang, T. Stacy, J. D. Miller, A. F. Lewis, T. L. Gu et al., The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo, Cell, vol.87, pp.697-708, 1996.

J. E. Draper, P. Sroczynska, O. Tsoulaki, H. S. Leong, M. Z. Fadlullah et al., RUNX1B Expression is highly heterogeneous and distinguishes megakaryocytic and erythroid lineage fate in adult mouse hematopoiesis, PLoS Genet, vol.12, p.1005814, 2016.

B. Niebuhr, N. Kriebitzsch, M. Fischer, K. Behrens, T. Gunther et al., Runx1 is essential at two stages of early murine B-cell development, Blood, vol.122, pp.413-423, 2013.

T. Davis-smyth, R. C. Duncan, T. Zheng, G. Michelotti, and D. Levens, The far upstream element-binding proteins comprise an ancient family of single-strand DNA-binding transactivators, J. Biol. Chem, vol.271, pp.31679-31687, 1996.

R. Duncan, L. Bazar, G. Michelotti, T. Tomonaga, H. Krutzsch et al., A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif, Genes Dev, vol.8, pp.465-480, 1994.

J. Zhang and Q. M. Chen, Far upstream element binding protein 1: a commander of transcription, translation and beyond, Oncogene, vol.32, pp.2907-2916, 2013.

M. I. Avigan, B. Strober, and D. Levens, A far upstream element stimulates c-myc expression in undifferentiated leukemia cells, J. Biol. Chem, vol.265, pp.18538-18545, 1990.

M. Malz, A. Weber, S. Singer, V. Riehmer, M. Bissinger et al., Overexpression of far upstream element binding proteins: A mechanism regulating proliferation and migration in liver cancer cells, Hepatology, vol.50, pp.1130-1139, 2009.

U. Rabenhorst, R. Beinoraviciute-kellner, M. Brezniceanu, S. Joos, F. Devens et al., Overexpression of the far upstream element binding protein 1 in hepatocellular carcinoma is required for tumor growth, Hepatology, vol.50, pp.1121-1129, 2009.

L. Guo, O. Zaysteva, Z. Nie, N. C. Mitchell, A. Lee et al., Defining the essential function of FBP/KSRP proteins: Drosophila Psi interacts with the mediator complex to modulate MYC transcription and tissue growth, Nucleic Acids Res, vol.44, pp.7646-7658, 2016.

P. Huang, J. Lin, N. Locker, Y. Kung, C. Hung et al., Far upstream element binding protein 1 binds the internal ribosomal entry site of enterovirus 71 and enhances viral translation and viral growth, Nucleic Acids Res, vol.39, pp.9633-9648, 2011.

N. Irwin, V. Baekelandt, L. Goritchenko, and L. I. Benowitz, Identification of two proteins that bind to a pyrimidine-rich sequence in the 3-untranslated region of GAP-43 mRNA, Nucleic Acids Res, vol.25, pp.1281-1288, 1997.

J. Lin, M. Li, and S. Shih, Far upstream element binding protein 2 interacts with enterovirus 71 internal ribosomal entry site and negatively regulates viral translation, Nucleic Acids Res, vol.37, pp.47-59, 2009.

J. Miro, A. M. Laaref, V. Rofidal, R. Lagrafeuille, S. Hem et al., FUBP1: a new protagonist in splicing regulation of the DMD gene, Nucleic Acids Res, vol.43, pp.2378-2389, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01279092

C. Bettegowda, N. Agrawal, Y. Jiao, M. Sausen, L. D. Wood et al., Mutations in CIC and FUBP1 contribute to human oligodendroglioma, Science, vol.333, pp.1453-1455, 2011.

S. Singer, M. Malz, E. Herpel, A. Warth, M. Bissinger et al., Coordinated expression of stathmin family members by far upstream sequence Element-Binding Protein-1 increases motility in Non-Small cell lung cancer, Cancer Res, vol.69, pp.2234-2243, 2009.

A. Weber, I. Kristiansen, M. Johannsen, B. Oelrich, K. Scholmann et al., The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer, BMC Cancer, vol.8, p.369, 2008.

L. Yang, J. Zhu, J. Zhang, B. Bao, C. Guan et al., Far upstream element-binding protein 1 (FUBP1) is a potential c-Myc regulator in esophageal squamous cell carcinoma (ESCC) and its expression promotes ESCC progression, Tumor Biol, vol.37, pp.4115-4126, 2016.

U. Rabenhorst, F. B. Thalheimer, K. Gerlach, M. Kijonka, S. B-¨-ohm et al., Single-Stranded DNA-Binding transcriptional regulator FUBP1 is essential for fetal and adult hematopoietic stem cell Self-Renewal, Cell Rep, vol.11, pp.1847-1855, 2015.
DOI : 10.1016/j.celrep.2015.05.038
URL : https://doi.org/10.1016/j.celrep.2015.05.038

W. Zhou, Y. Chung, E. R. Parrilla-castellar, Y. Zheng, H. Chung et al., Far upstream element binding protein plays a crucial role in embryonic development, hematopoiesis, and stabilizing Myc expression levels, Am. J. Pathol, vol.186, pp.701-715, 2016.
DOI : 10.1016/j.ajpath.2015.10.028
URL : http://europepmc.org/articles/pmc4816710?pdf=render

P. Klener, E. Fronkova, A. Berkova, R. Jaksa, H. Lhotska et al., Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years: Mantle cell lymphoma-variant Richter syndrome, Int. J. Cancer, vol.139, pp.2252-2260, 2016.

C. M. Lindqvist, A. Lundmark, J. Nordlund, E. Freyhult, D. Ekman et al., Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes, Oncotarget, vol.7, pp.64071-64088, 2016.
DOI : 10.18632/oncotarget.11773
URL : http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=11773&path%5B%5D=37230

D. A. Landau, E. Tausch, A. N. Taylor-weiner, C. Stewart, J. G. Reiter et al., Mutations driving CLL and their evolution in progression and relapse, Nature, vol.526, pp.525-530, 2015.
DOI : 10.1038/nature15395
URL : http://europepmc.org/articles/pmc4815041?pdf=render

L. K. Ashman, The biology of stem cell factor and its receptor C-kit, Int. J. Biochem. Cell Biol, vol.31, pp.1037-1051, 1999.

V. C. Broudy, Stem cell factor and hematopoiesis, Blood, vol.90, pp.1345-1364, 1997.

M. Miettinen and J. Lasota, KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation, Appl. Immunohistochem. Mol. Morphol, vol.13, pp.205-220, 2005.
DOI : 10.1097/01.pai.0000173054.83414.22
URL : https://zenodo.org/record/1234861/files/article.pdf

Y. Yarden, W. J. Kuang, T. Yang-feng, L. Coussens, S. Munemitsu et al., Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand, EMBO J, vol.6, pp.3341-3351, 1987.
DOI : 10.1002/j.1460-2075.1987.tb02655.x

H. Mohammed, C. Santos, A. A. Serandour, H. R. Ali, G. D. Brown et al., Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor, Cell Rep, vol.3, pp.342-349, 2013.
DOI : 10.1016/j.celrep.2013.01.010
URL : https://doi.org/10.1016/j.celrep.2013.01.010

L. Debaize, H. Jakobczyk, A. Rio, V. Gandemer, and M. Troadec, Optimization of proximity ligation assay (PLA) for detection of protein interactions and fusion proteins in non-adherent cells: application to pre-B lymphocytes, Mol. Cytogenet, vol.10, p.27, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01578071

S. A. Stewart, D. M. Dykxhoorn, D. Palliser, H. Mizuno, E. Y. Yu et al., Lentivirus-delivered stable gene silencing by RNAi in primary cells, RNA, vol.9, pp.493-501, 2003.

M. Arnaud, A. Vallée, G. Robert, J. Bonneau, C. Leroy et al., CD9, a key actor in the dissemination of lymphoblastic leukemia, modulating CXCR4-mediated migration via RAC1 signaling, Blood, vol.126, pp.1802-1812, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01196601

E. Campeau, V. E. Ruhl, F. Rodier, C. L. Smith, B. L. Rahmberg et al., A versatile viral system for expression and depletion of proteins in mammalian cells, PLoS ONE, vol.4, p.6529, 2009.

A. A. Sérandour, S. Avner, F. Oger, M. Bizot, F. Percevault et al., Dynamic hydroxymethylation of deoxyribonucleic acid marks differentiation-associated enhancers, Nucleic Acids Res, vol.40, pp.8255-8265, 2012.

H. Shin, T. Liu, A. K. Manrai, and X. S. Liu, CEAS: cis-regulatory element annotation system, Bioinforma. Oxf. Engl, vol.25, pp.2605-2606, 2009.

C. Y. Mclean, D. Bristor, M. Hiller, S. L. Clarke, B. T. Schaar et al., GREAT improves functional interpretation of cis-regulatory regions, Nat. Biotechnol, vol.28, pp.495-501, 2010.

N. `-egre, D. Mangeot, P. E. Duisit, G. Blanchard, S. Vidalain et al., Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells, Gene Ther, vol.7, pp.1613-1623, 2000.

Y. Zheng and W. K. Miskimins, Far upstream element binding protein 1 activates translation of p27Kip1 mRNA through its internal ribosomal entry site, Int. J. Biochem. Cell Biol, vol.43, pp.1641-1648, 2011.

E. Krieger and G. Vriend, New ways to boost molecular dynamics simulations, J. Comput. Chem, vol.36, pp.996-1007, 2015.

L. He, A. Weber, and D. Levens, Nuclear targeting determinants of the far upstream element binding protein, a c-myc transcription factor, Nucleic Acids Res, vol.28, pp.4558-4565, 2000.

J. Lu, M. Maruyama, M. Satake, S. C. Bae, E. Ogawa et al., Subcellular localization of the alpha and beta subunits of the acute myeloid leukemia-linked transcription factor PEBP2/CBF, Mol. Cell. Biol, vol.15, pp.1651-1661, 1995.

A. Zelent, M. Greaves, and T. Enver, Role of the TEL-AML1 fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemia, Oncogene, vol.23, pp.4275-4283, 2004.

F. Melchers, Checkpoints that control B cell development, J. Clin. Invest, vol.125, pp.2203-2210, 2015.

B. S. Atanassov and S. Y. Dent, USP22 regulates cell proliferation by deubiquitinating the transcriptional regulator FBP1, EMBO Rep, vol.12, pp.924-930, 2011.

U. Rabenhorst, R. Beinoraviciute-kellner, M. Brezniceanu, S. Joos, F. Devens et al., Overexpression of the far upstream element binding protein 1 in hepatocellular carcinoma is required for tumor growth, Hepatol. Baltim. Md, vol.50, pp.1121-1129, 2009.

M. Malz, M. Bovet, J. Samarin, U. Rabenhorst, C. Sticht et al., Overexpression of far upstream element (FUSE) binding protein (FBP)-interacting repressor (FIR) supports growth of hepatocellular carcinoma, Hepatology, vol.60, pp.1241-1250, 2014.

D. T. Braddock, J. M. Louis, J. L. Baber, D. Levens, and G. M. Clore, Structure and dynamics of KH domains from FBP bound to single-stranded DNA, Nature, vol.415, pp.1051-1056, 2002.

D. Levanon and Y. Groner, Structure and regulated expression of mammalian RUNX genes, Oncogene, vol.23, pp.4211-4219, 2004.

A. Sandelin, W. Alkema, P. Engströmengstr¨engström, W. W. Wasserman, and B. Lenhard, JASPAR: an open-access database for eukaryotic transcription factor binding profiles, Nucleic Acids Res, vol.32, pp.91-94, 2004.

C. J. Matheny, M. E. Speck, P. R. Cushing, Y. Zhou, T. Corpora et al., Disease mutations in RUNX1 and RUNX2 create nonfunctional, dominant-negative, or hypomorphic alleles, EMBO J, vol.26, pp.1163-1175, 2007.

L. Zhang, Z. Li, J. Yan, P. Pradhan, T. Corpora et al., Mutagenesis of the Runt domain defines two energetic hot spots for heterodimerization with the core binding factor beta subunit, J. Biol. Chem, vol.278, pp.33097-33104, 2003.

L. R. Benjamin, H. Chung, S. Sanford, F. Kouzine, J. Liu et al., Hierarchical mechanisms build the DNA-binding specificity of FUSE binding protein, Proc. Natl. Acad. Sci. U.S.A, vol.105, pp.18296-18301, 2008.

H. Siomi, M. J. Matunis, W. M. Michael, and G. Dreyfuss, The pre-mRNA binding K protein contains a novel evolutionarily conserved motif, Nucleic Acids Res, vol.21, pp.1193-1198, 1993.

G. Sully, J. L. Dean, R. Wait, L. Rawlinson, T. Santalucia et al., Structural and functional dissection of a conserved destabilizing element of cyclo-oxygenase-2 mRNA: evidence against the involvement of AUF-1 [AU-rich element/poly(U)-binding/degradation factor-1], AUF-2, tristetraprolin, HuR (Hu antigen R) or FBP1 (far-upstream-sequence-element-binding protein 1), Biochem. J, vol.377, pp.629-639, 2004.

X. Zhou, M. N. Edmonson, M. R. Wilkinson, A. Patel, G. Wu et al., Exploring genomic alteration in pediatric cancer using ProteinPaint, Nat. Genet, vol.48, pp.4-6, 2016.

J. Lennartsson, T. Jelacic, D. Linnekin, and R. Shivakrupa, Normal and oncogenic forms of the receptor tyrosine kinase kit, Stem Cells, vol.23, pp.16-43, 2005.

N. S. Yee, C. W. Hsiau, H. Serve, K. Vosseller, and P. Besmer, Mechanism of down-regulation of c-kit receptor. Roles of receptor tyrosine kinase, phosphatidylinositol 3-kinase, and protein kinase C, J. Biol. Chem, vol.269, pp.31991-31998, 1994.

L. He, J. Liu, I. Collins, S. Sanford, B. O'connell et al., Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression, EMBO J, vol.19, pp.1034-1044, 2000.

J. Cammenga, S. Horn, U. Bergholz, G. Sommer, P. Besmer et al., Extracellular KIT receptor mutants, commonly found in core binding factor AML, are constitutively active and respond to imatinib mesylate, Blood, vol.106, pp.3958-3961, 2005.
DOI : 10.1182/blood-2005-02-0583
URL : http://www.bloodjournal.org/content/bloodjournal/106/12/3958.full.pdf

Y. Tian, G. Wang, Q. Hu, X. Xiao, and S. Chen, AML1/ETO trans-activates c-KIT expression through the long range interaction between promoter and intronic enhancer, J. Cell. Biochem, vol.119, pp.3706-3715, 2017.
DOI : 10.1002/jcb.26587

J. Liu, L. He, I. Collins, H. Ge, D. Libutti et al., The FBP interacting repressor targets TFIIH to inhibit activated transcription, Mol. Cell, vol.5, pp.331-341, 2000.
DOI : 10.1016/s1097-2765(00)80428-1
URL : https://doi.org/10.1016/s1097-2765(00)80428-1

J. Liu, H. Chung, M. Vogt, Y. Jin, D. Malide et al., JTV1 co-activates FBP to induce USP29 transcription and stabilize p53 in response to oxidative stress, EMBO J, vol.30, pp.846-858, 2011.
DOI : 10.1038/emboj.2011.11
URL : http://emboj.embopress.org/content/embojnl/30/5/846.full.pdf

K. W. Sykora, J. Tomeczkowski, and A. Reiter, C-Kit receptors in childhood malignant lymphoblastic cells, Leuk. Lymphoma, vol.25, pp.201-216, 1997.
DOI : 10.3109/10428199709114160

A. Andersson, T. Olofsson, D. Lindgren, B. Nilsson, C. Ritz et al., Molecular signatures in childhood acute leukemia and their correlations to expression patterns in normal hematopoietic subpopulations, Proc. Natl. Acad. Sci. U.S.A, vol.102, pp.19069-19074, 2005.

H. Ikeda, Y. Kanakura, T. Tamaki, A. Kuriu, H. Kitayama et al., Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells, Blood, vol.78, pp.2962-2968, 1991.

R. R. Weidemann, R. Behrendt, K. B. Schoedel, W. Uller, A. Roers et al., Constitutive Kit activity triggers B-cell acute lymphoblastic leukemia-like disease in mice, Exp. Hematol, vol.45, pp.45-55, 2017.
DOI : 10.1016/j.exphem.2016.09.005
URL : https://www.research.manchester.ac.uk/portal/files/46174468/1_s2.0_S0301472X16306154_main.pdf

K. Eppert, K. Takenaka, E. R. Lechman, L. Waldron, B. Nilsson et al., Stem cell gene expression programs influence clinical outcome in human leukemia, Nat. Med, vol.17, pp.1086-1093, 2011.
DOI : 10.1038/nm.2415

V. Gandemer, A. G. Rio, M. De-tayrac, V. Sibut, S. Mottier et al., Five distinct biological processes and 14 differentially expressed genes characterize TEL/AML1-positive leukemia, BMC Genomics, vol.8, p.385, 2007.
DOI : 10.1186/1471-2164-8-385
URL : https://hal.archives-ouvertes.fr/hal-01068393

X. Jiao, B. T. Sherman, D. W. Huang, R. Stephens, M. W. Baseler et al., DAVID-WS: a stateful web service to facilitate gene/protein list analysis, Bioinformatics, vol.28, pp.1805-1806, 2012.
DOI : 10.1093/bioinformatics/bts251
URL : https://academic.oup.com/bioinformatics/article-pdf/28/13/1805/641736/bts251.pdf

J. W. Nicol, G. A. Helt, S. G. Blanchard, A. Raja, and A. E. Loraine, The integrated genome Browser: free software for distribution and exploration of genome-scale datasets, Bioinforma. Oxf. Engl, vol.25, pp.2730-2731, 2009.

R. Chenna, H. Sugawara, T. Koike, R. Lopez, T. J. Gibson et al., Multiple sequence alignment with the Clustal series of programs, Nucleic Acids Res, vol.31, pp.3497-3500, 2003.

R. G. Efremov, A. O. Chugunov, T. V. Pyrkov, J. P. Priestle, A. S. Arseniev et al., Molecular lipophilicity in protein modeling and drug design, Curr. Med. Chem, vol.14, pp.393-415, 2007.
DOI : 10.2174/092986707779941050